The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Expudyne Rx 750 mg/5 ml oral solution



JED Pharma LimitedPA23183/005/001

Main Information

Trade NameExpudyne Rx 750 mg/5 ml oral solution
Active SubstancesCarbocisteine
Dosage FormOral solution
Licence HolderJED Pharma Limited
Licence NumberPA23183/005/001

Group Information

ATC CodeR05CB03 carbocisteine

Status

License statusAuthorised
Licence Issued31/03/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back